 |
|
|
| |
Switching From Atripla to a Tenofovir Alafenamide-Based Single-Tablet Regimen: Week-48 Data in Virologically Suppressed Adults
|
| |
| |
Reported by Jules Levin
ICAAC 2015 Sept 17-21 2015 San Diego, CA
David Shamblaw,1 Jan Van Lunzen,2 Chloe Orkin,3 Mark Bloch,4 Ploenchan Chetchotisakd,5 Bart Rijnders,6 Jason Flamm,7 Catherine Creticos,8 Andrew Plummer,9 YaPei Liu,9 Andrew Cheng,9 Scott McCallister9 on behalf of the Gilead GS-US-292-0109 Study Team
1La Playa Medical Group, San Diego, CA; 2Universitatsklinikum Hamburg-Eppendorf, Hamburg, Germany; 3St Bartholomew's and the Royal London Hospital, London, UK; 4Holdsworth House Medical Practice, Darlinghurst, New South Wales, Australia; 5Srinagarind Hospital, Khan Kaen, Thailand; 6Erasmus Medical Center, Rotterdam, the Netherlands; 7Kaiser Permanente, Sacramento, CA; 8Howard Brown Health Center, Chicago, IL; 9Gilead Sciences, Inc., Foster City, CA.
|
| |
|
|
|
|
|
